Biotron Statistics
Total Valuation
Biotron has a market cap or net worth of 6.73 million. The enterprise value is 6.07 million.
| Market Cap | 6.73M |
| Enterprise Value | 6.07M |
Important Dates
The next estimated earnings date is Monday, February 23, 2026.
| Earnings Date | Feb 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 2.41B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +10.76% |
| Shares Change (QoQ) | +10.51% |
| Owned by Insiders (%) | 19.79% |
| Owned by Institutions (%) | 0.43% |
| Float | 2.00B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.66 |
| PB Ratio | 18.60 |
| P/TBV Ratio | 18.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -29.05 |
| EV / Sales | 4.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -16.27 |
Financial Position
The company has a current ratio of 2.23
| Current Ratio | 2.23 |
| Quick Ratio | 2.19 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -23.16 |
Financial Efficiency
Return on equity (ROE) is -206.96% and return on invested capital (ROIC) is -134.43%.
| Return on Equity (ROE) | -206.96% |
| Return on Assets (ROA) | -28.73% |
| Return on Invested Capital (ROIC) | -134.43% |
| Return on Capital Employed (ROCE) | -61.38% |
| Weighted Average Cost of Capital (WACC) | 0.08% |
| Revenue Per Employee | 396,343 |
| Profits Per Employee | -69,620 |
| Employee Count | 3 |
| Asset Turnover | 2.46 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.41% in the last 52 weeks. The beta is -0.76, so Biotron's price volatility has been lower than the market average.
| Beta (5Y) | -0.76 |
| 52-Week Price Change | -75.41% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 45.31 |
| Average Volume (20 Days) | 35,004 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biotron had revenue of 1.19 million and -208,859 in losses. Loss per share was -0.00.
| Revenue | 1.19M |
| Gross Profit | 1.19M |
| Operating Income | -222,088 |
| Pretax Income | -208,859 |
| Net Income | -208,859 |
| EBITDA | -218,846 |
| EBIT | -222,088 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 610,815 in cash and n/a in debt, with a net cash position of 610,815.
| Cash & Cash Equivalents | 610,815 |
| Total Debt | n/a |
| Net Cash | 610,815 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 361,827 |
| Book Value Per Share | 0.00 |
| Working Capital | 345,436 |
Cash Flow
In the last 12 months, operating cash flow was -370,943 and capital expenditures -2,013, giving a free cash flow of -372,956.
| Operating Cash Flow | -370,943 |
| Capital Expenditures | -2,013 |
| Free Cash Flow | -372,956 |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -18.68% and -17.57%.
| Gross Margin | 100.00% |
| Operating Margin | -18.68% |
| Pretax Margin | -17.57% |
| Profit Margin | -17.57% |
| EBITDA Margin | -18.41% |
| EBIT Margin | -18.68% |
| FCF Margin | n/a |
Dividends & Yields
Biotron does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.76% |
| Shareholder Yield | -10.76% |
| Earnings Yield | -3.10% |
| FCF Yield | -5.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Biotron has an Altman Z-Score of -62.27 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -62.27 |
| Piotroski F-Score | 2 |